Abbott Q4 2024 Earnings Call. Turning to our outlook for 2024, today, we issued guidance for full year adjusted earnings per share of $4.50 to $4.70, which includes an adjusted earnings per share forecast of $0.93 to. Turning to our outlook for 2024, today, we issued guidance for full year adjusted earnings per share of $4.50 to $4.70, which includes an adjusted earnings per share forecast.
Abbott’s q4 organic sales grew by 11%, with a slight negative impact from foreign exchange. Abt) q4 2023 earnings call transcript january 24, 2024.
Guidance For Gaap Diluted Eps Is $3.20 To $3.40.
Abt) q4 2023 earnings call transcript january 24, 2024.
Turning To Our Outlook For 2024, Today, We Issued Guidance For Full Year Adjusted Earnings Per Share Of $4.50 To $4.70, Which Includes An Adjusted Earnings Per Share Forecast Of $0.93 To.
Abbott anticipates an 8% to 10% sales growth in 2024, excluding covid testing sales, and expects adjusted earnings per share to be between $4.50 and $4.70.
Today, We Issued Guidance For Full Year Adjusted Earnings Per Share Of $4.50 To $4.70, Which Includes An Adjusted Earnings Per Share Forecast Of $0.93 To $0.97 For The First.
Images References :
Guidance For Gaap Diluted Eps Is $3.20 To $3.40.
Abbott laboratories (nyse:abt) q4 2022 earnings conference call january 25, 2023 9:00 am et.
Abbott Anticipates An 8% To 10% Sales Growth In 2024, Excluding Covid Testing Sales, And Expects Adjusted Earnings Per Share To Be Between $4.50 And $4.70.
Turning to our outlook for 2024, today, we issued guidance for full year adjusted earnings per share of $4.50 to $4.70, which includes an adjusted earnings per share forecast.
Abbott Laboratories (Nyse:nyse:abt) Q4 2023 Earnings Conference Call January 24, 2024 9:00 Am Etcompany Participantsmike.